Digital twins in drug development, Top 10 Organoid Companies, Inside preclinical NAMs innovation, Novel bioprinting method, and more

NAMs News

Actus des méthodes non-animales

MAY 11 - 15, 2026

Pro Anima > Actualités > NAMs News - MAY 11 - 15, 2026
Digital twins in drug development, Top 10 Organoid Companies, Inside preclinical NAMs innovation, Novel bioprinting method, and more
NAMs News - APRIL 27 - MAY 1, 2026

Effectiveness of VCGs in toxicology, Institutional biobanking, PARC training on in silico models, Mimetas Tumor – Vasculature-on-Chip, and more

NEWS, REPORTS & POSITION STATEMENTS 1. Charles River highlights effectiveness of VCGs in toxicology Charles River Laboratories International has shared […]

Read more
NAMs News - APRIL 20 - 24, 2026

The Merck “3 Baskets” approach, Future Market Insights report on the OOC market, Anivance AI selected by the FNIH NAMs pilot, OpenAI Foundation for Alzheimer, and more

NEWS, REPORTS & POSITION STATEMENTS 1. The Merck “3 Baskets” approach for creating roadmaps to phase out animal testing In […]

Read more
NAMs News - APRIL 13 - 17, 2026

ICH S7A revised after 25 Years, Harmonized definition for NAMs, OOC into space, Personalized models of Schizophrenia, and more

NEWS, REPORTS & POSITION STATEMENTS 1. ICH S7A revised after 25 Years: Why it matters for NAMs developers The International […]

Read more
NAMs News - APRIL 06 - 10 2026

Standardizing NAMs, 2025 ECVAM Status Report, Anthropic’s life sciences strategy, Non-clinical safety assessment of vaccines, and more

NEWS, REPORTS & POSITION STATEMENTS 1. Novo Nordisk principal scientist highlights the urgency of advancing human-relevant 3D tissue models As […]

Read more
NAMs News - MARCH 30 - APRIL 03, 2026

UK regulatory guidance for NAMs, Nature collection on organoid models for infectious diseases, AI agents in drug discovery and more

NEWS, REPORTS & POSITION STATEMENTS 1. UK: MHRA published guidance on its approach to medicines developed using non-animal methods The […]

Read more
NAMs News - MARCH 23 - 27, 2026

FDA draft guidance on NAMs for industry, NIH’s $150 million investment, Swiss 3RCC report, PEPPER call for partner laboratories, Cell-Microgel Biohybrid Spheroids, and more

NEWS, REPORTS & POSITION STATEMENTS 1. FDA: General considerations for the use of NAMs in drug development The Food and […]

Read more
NAMs News - MARCH 16 - 20, 2026

Agentic AI in biomedical research, Two decades of iPSC research, Vascularizing OOC, and more

NEWS, REPORTS & POSITION STATEMENTS 1. Agentic AI and the rise of in silico team science in biomedical research Agentic […]

Read more
NAMs News - MARCH 09 - 13, 2026

AI-Ready evaluation for Antimicrobial Resistance Research, BEACON consortium, Bruker x Noetik spatial AI models, iPSC-derived multi-organ PK/PD, and more

NEWS, REPORTS & POSITION STATEMENTS 1. Global community effort to shape new AI-ready datasets and evaluations for Antimicrobial Resistance Research […]

Read more
NAMs News - March 02 - 06, 2026

NAMs Landscape in India, French LIFT Industrial Chair, VISI-ON-BRAIN doctoral network, A human mini-bladder, and more

NEWS, REPORTS & POSITION STATEMENTS 1. India: Landscape analysis on alternatives for drug development The landscape of drug development is […]

Read more
NAMs News - FEBRUARY 23 - 27, 2026

World’s first iPSC-derived drugs approval in Japan, ERA Act, Innovate UK funding, Roche new high-tech center, Human spinal cord organoids, and more

NEWS, REPORTS & POSITION STATEMENTS 1. Japan endorses two iPSC-derived drugs for approval Japan, through a Ministry of Health committee, […]

Read more
NAMs News - FEBRUARY 16 - 20, 2026

Modern risks assessments, Human relevant pre-clinical models, Big pharma’s China deal wave, Intelligent sensors cell production, and more

NEWS, REPORTS & POSITION STATEMENTS 1. Transforming chemicals and cosmetics assessment Carcinogenicity assessment Assessing the safety of chemicals used in […]

Read more
NAMs News - FEBRUARY 09 - 13, 2026

EU IVB competitiveness, IAMPS launch, 2027 DVES Prize call, Industrializing global cell therapy, Big Data and T2 Diabetes, and more

NEWS, REPORTS & POSITION STATEMENTS 1. Strengthening the competitiveness of EU in vitro biotechnologies In vitro biotechnology (IVB) is a […]

Read more
Donate
MENU